QuidelOrtho reported a 10.5% revenue decline to $620 million in Q1 2026, driven by a weak respiratory season and disruptions in China and the Middle East. The company posted a GAAP net loss of $92 million but highlighted growth in immunohematology and completed the LEX Diagnostics acquisition to boost molecular diagnostics. It lowered its full-year 2026 revenue and earnings guidance due to ongoing market challenges and pending China pricing guideline changes. QuidelOrtho remains focused on expanding margins and cash flow with new product launches in the U.S. and international markets.
Air Comm, a leading provider of wireless communication and security technology, has opened a new office in Farmers Branch, Texas, expanding its presence in the Dallas-Fort Worth area. This new location enhances Air Comm's ability to offer faster loca...
Metallium Limited has successfully operated three Flash Joule Heating units simultaneously at its Texas facility, marking a key milestone in scaling its proprietary technology. The operation achieved 83% availability and nearly 100% utilization, exce...
iRhythm Holdings disclosed a cybersecurity breach involving unauthorized access to data on third-party business applications. Hackers claimed to have sensitive company and patient information and demanded payment to avoid public release. The company ...
On June 15, 2026, BlackRock, Inc. and its funds reduced their total holdings in Orion Corporation to below 5% of the company's shares and voting rights. This change was disclosed under the Finnish Securities Market Act, indicating a decrease from a p...
BlackRock, Inc. has reported that its direct and indirect ownership in Orion Oyj has dropped below the 5% threshold as of June 15, 2026. This change requires a formal disclosure under Finnish securities law. The reduction in BlackRock's stake may aff...
